基本信息
views: 0
Career Trajectory
Bio
主要研究方向为单B细胞测序及全人源抗体制备技术,抗肿瘤治疗性抗体及相关药物开发,肿瘤免疫治疗及转化研究。承担及参与国家“863“、”973“、国家自然科学基因项目及省部级基金课题等30余个项目,在肿瘤分子病理学、肿瘤发病机制、抗体药物研发、肿瘤免疫细胞治疗等研究领域取得了较为突出的成绩。获全军科学技术奖二等奖2项,江苏省科技进步三等奖1项,江苏省预防医学奖一等奖1项。代表论文发表在PNAS,Hematol Oncol,Pharmacol Res等杂志,研制及开发靶向cMet、Trop2、TLR4、VEGFR2等治疗性抗体,抗新冠病毒RBD、炭疽、狂犬病、HCMV等中和性抗体及靶向c-Met、TROP2系列 CAR-T、CAR-NK细胞,获得国家发明专利授权27项。
Research Interests
Papers共 143 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
JOURNAL OF PROTEOME RESEARCHno. 4 (2024): 1370-1378
Yuan Mao, Yufeng Chen, Xiaohui Yang, Yiting He, Daixun Cui, Wen Huang, Lihua Jiang, Xiaoli Zhou, Xinxia Chang,Jin Zhu, Yi Zhu,Qi Tang, Zhenqing Feng, Louqian Zhang,Kuirong Jiang, Hao Yuan
Cancer Letterspp.217382, (2024)
JOURNAL OF THE AMERICAN CHEMICAL SOCIETYno. 31 (2024): 22008-22016
INTERNATIONAL IMMUNOPHARMACOLOGY (2024)
Clinical genitourinary cancerno. 6 (2024): 102192-102192
ANALYTICAL LETTERS (2024)
Bladder (San Francisco, Calif)no. 1 (2024): e21200003-e21200003
INTERNATIONAL BRAZ J UROLno. 6 (2024)
MATERIALS TODAY NANO (2024)
Load More
Author Statistics
#Papers: 143
#Citation: 1578
H-Index: 23
G-Index: 35
Sociability: 6
Diversity: 3
Activity: 68
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn